« Back to Record
Body, J.-J., Diel, I., Tripathy, D., & Bergström, B. (2006). Intravenous ibandronate does not affect time to renal function deterioration in patients with skeletal metastases from breast cancer: Phase III trial results. European journal of cancer care, 15(3), 299-302. doi:10.1111/j.1365-2354.2005.00641.x
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/83370



